CELL INTELLIGENCE · 肿瘤细胞治疗研究

CAR-T 细胞治疗在儿童、青少年和年轻成人癌症患者中的关键作用

The quintessential role for CAR T cell therapy in children, adolescents and young adults with cancer.

CAR mRNA 工程化 T 细胞与巨噬细胞在清除 CD19⁺ 白血病细胞中的不同效应功能与协同作用

Distinct effector functions and synergy of CAR mRNA-engineered T cells and macrophages in the clearance of CD19(+) leukemia cells.

我们的研究结果凸显了 CAR-T 细胞优越的肿瘤细胞杀伤能力。

溶瘤病毒与 CAR-T 细胞基因治疗的进展及治疗相关分组

Advances in Gene Therapy with Oncolytic Viruses and CAR-T Cells and Therapy-Related Groups.

增强 CAR-T 细胞：在体内白血病模型中经植物血凝素激活释放持久作用潜力

Enhancing CAR-T cells: unleashing lasting impact potential with phytohemagglutinin activation in in vivo leukemia model.

靶向 T-ALL 的通用型抗 CD7 CAR-T 细胞及 T/CAR-T 细胞上 CD7 抗原的功能分析

Universal Anti-CD7 CAR-T Cells Targeting T-ALL and Functional Analysis of CD7 Antigen on T/CAR-T Cells.

Kymriah®（tisagenlecleucel）：首个获批 CAR-T 疗法临床开发历程概述

Kymriah® (tisagenlecleucel) - An overview of the clinical development journey of the first approved CAR-T therapy.

双靶向 CAR-T 细胞疗法治疗复发/难治性 B 细胞淋巴系统恶性肿瘤的疗效与安全性：系统评价与 Meta 分析

Efficacy and Safety of Dual-Targeting Chimeric Antigen Receptor-T Therapy for Relapsed or Refractory B Cell Lymphoid Malignancies: A Systematic Review

复发/难治性 B 细胞急性淋巴细胞白血病中自体抗 CD19CAR-T 细胞的长期反应：系统综述和 meta 分析

Long-term response to autologous anti-CD19 chimeric antigen receptor T cells in relapsed or refractory B cell acute lymphoblastic leukemia: a systemat

符合 cGMP 的供者来源、CD45RA 去除记忆型 CD19-CAR-T 细胞制备工艺的开发

Development of a cGMP-compliant process to manufacture donor-derived, CD45RA-depleted memory CD19-CAR T cells.

在欧洲开发学术性 CAR-T 细胞，医院豁免是欧洲药品管理局的替代方案还是桥梁？我们的 ARI-0001 经验

Is Hospital Exemption an Alternative or a Bridge to European Medicines Agency for Developing Academic Chimeric Antigen Receptor T-Cell in Europe? Our